Skip to main content
Signal8

Lunai Bioworks Inc. (LNAI)

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Lunai Bioworks Inc. logo

Lunai Bioworks Inc.

OTC:LNAIOTC (delisted from Nasdaq, Form 25 effective Nov 12, 2026)Healthcare
Mkt Cap$830K
EV$454K
Float4.88M
O/S5.03M
VOL1.27M sh
$ Vol$195K
RVOL0.86×
Inst Own3.8%
SI0.4%
Net Cash/Sh+$0.07
Dilution
Financials Summary
Revenue$52K
Net Income-$3.56M
Total Assets$9.94M
Free Cash Flow-$5.29M
Debt & Equity
Total Debt$1.34M
Total Equity-$9.02M
Shares Outstanding
Short Interest

No short interest data available.

Split History2 splits · 2 reverse
2-year cumulative
1:80

Nasdaq bars a compliance period at 1:250

  1. 1:8Reverse split
    May 22, 20268 shares → 1
  2. 1:10Reverse split
    Sep 30, 202510 shares → 1
Balance Sheet Details
Assets$9.94M
Liabilities$18.97M
Accounts Receivable$0
Accounts Payable$12.39M
Inventory$0
PP&E (Net)$12K
Goodwill$5.96M
Intangible Assets$1.93M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-30
Revenue$52K$0$0$0$0$0
YoY Growth------
Cost of Revenue$94K$129K$0$0$0$391K
Gross Profit-$42K-$129K$0$0$0-$391K
Gross Margin-79.9%-----
Research and Development$24.52M$537K$2.71M$4.17M$8.37M$15.54M
Selling, General, and Administrative$7.8B$17.88M$24.56M$15.32M$14.33M$7.47M
Other-$7.82B$0$54.37M$19.07M$93.38M$0
Total Operating Expenses$7.82M$18.42M$81.64M$38.56M$116.08M$23.01M
Operating Income (EBIT)-$7.87M-$18.55M-$81.64M-$38.56M-$116.08M-$23.4M
Operating Margin-15129.3%-----
Interest Expense$235K$726K$2.43M$707K$373K$380K
Interest Income$0$116K$0$0$122K$13K
Other Income (Expense)$4.3M-$159.46M-$6.79M-$1.13M$2.65M-$3.45M
Income Before Tax (EBT)-$3.56M-$178.01M-$88.43M-$39.68M-$113.43M-$26.85M
Income Tax Expense$0$0$0$0$34-$125K
Net Income-$3.56M-$178.01M-$88.43M-$39.68M-$113.43M-$26.72M
Net Income Margin-6852.0%-----
Supplementary Data
EPS-1.06-86.24-72.80-56.80-172.80-45.36
Diluted EPS-1.06-86.24-72.80-56.80-172.80-45.36
Weighted Average OS3.36M2.06M1.22M703,317656,600589,591
EBITDA-$7.77M-$177.15M-$85.87M-$38.86M-$112.94M-$26.08M
EBITDA Margin-14949.4%-----
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-30
Assets
Current Assets
Cash and Cash Equivalents$1.71M$93K$220K$1.87M$9.17M$20.66M
Short-Term Investments$0$388K$0$0$0$0
Cash and Short-Term Investments$1.71M$481K$220K$1.87M$9.17M$20.66M
Accounts Receivable$0$0$1.11M$0$0$2K
Inventory$0$0$0$0$0$0
Other Current Assets$0$566K$669K$691K$393K$0
Total Current Assets$2.04M$1.05M$2M$2.57M$9.57M$20.9M
Long-Term Assets
Property, Plant & Equipment Net$12K$1.06M$1.75M$1.42M$1.74M$2.16M
Goodwill$5.96M$5.96M$159.33M$11.64M$11.64M$11.64M
Intangible Assets$1.93M$166K$30K$42.65M$61.62M$154.89M
Long-Term Investments$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0
Other Long-Term Assets$0$0$20K$22K$69K$21K
Total Long-Term Assets$7.91M$7.18M$161.13M$55.74M$75.07M$168.71M
Other Assets$0$0$0$0$0$0
Total Assets$9.94M$8.23M$163.13M$58.3M$84.63M$189.61M
Liabilities
Current Liabilities
Accounts Payable$12.39M$12.56M$9.45M$5.3M$1.4M$321K
Short-Term Debt$988K$9.44M$2.45M$4.62M$1.2M$353K
Current Income Tax Payable$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0
Other Current Liabilities$219K$1.01M$12.61M$185K$2.56M$1.21M
Total Current Liabilities$18.91M$29.16M$30.31M$11.02M$6.45M$1.89M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$4.58M$5.78M
Long-Term Unearned Revenue$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$6.04M
Total Long-Term Liabilities$56K$425K$842K$776K$5.56M$13.06M
Other Liabilities$0$0$0$0$0$0
Total Liabilities$18.97M$29.58M$31.15M$11.8M$12.01M$14.94M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0
Common Stock$462$18K$16K$6K$5K$5K
Retained Earnings-$514.03M-$510.46M-$332.46M-$244.03M-$204.35M-$90.91M
Comprehensive Income & Other-$156K$10.81M-$171K-$30K-$30K-$11K
Other Stockholders' Equity$505M$489.09M$464.42M$290.52M$276.96M$265.57M
Total Equity-$9.02M-$21.35M$131.98M$46.5M$72.62M$174.66M
Minority Interest$0$0$0$0$0$0
Total Liabilities and Equity$9.94M$8.23M$163.13M$58.3M$84.63M$189.61M
Supplementary Data
Total Debt$1.34M$10.17M$3.79M$5.59M$7.02M$7.37M
Net Debt-$375K$10.08M$3.57M$3.72M-$2.16M-$13.29M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-30
Operating Activities
Net Income-$3.56M-$178.01M-$88.43M-$39.68M-$113.43M-$26.72M
Depreciation & Amortization$94K$129K$122K$113K$124K$391K
Deferred Income Tax$0$0$0$0$0$0
Stock-Based Compensation$630K$3.31M$4.67M$3.54M$5.49M$0
Changes in Working Capital:
  Accounts Receivable$55K$1.15M-$1.11M$46$2K$342
  Inventory$0$0$0$0$0$0
  Accounts Payable$1.13M$3.11M$4.06M$3.89M$1.08M-$272K
  Other Working Capital$556K$1.6M$5.86M$410K$332K$1.2M
Total Working Capital Change$1.74M$5.86M$8.81M$4.31M$1.42M$932K
Other Non-Cash Items-$160.83M$63.85M$19.96M$90.67M$4.79M
Net Cash from Operating-$5.29M-$7.87M-$10.97M-$11.77M-$15.73M-$20.61M
Investing Activities
Capital Expenditures-$1K$0-$70K-$30K-$5K-$49K
Acquisitions$0$0-$1.19M$0$0$0
Purchases of Investments$0-$500K$0$0$0$0
Sales of Investments$545K$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0
Net Cash from Investing$543K-$500K-$1.26M-$30K-$5K-$49K
Financing Activities
Debt Repaid--$6.98M-$8.05M-$561K-
Common Stock Issuance$5.8M$2.38M$3M$4.01M$4.68M$31.93M
Common Stock Repurchases$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0
Other Financing Activities--$971K-$528K$503K$135K$1.22M
Net Cash from Financing$6.39M$8.38M$10.52M$4.52M$4.25M$32.6M
Forex Effect-$26K-$136K$60K-$8K-$5K$26K
Net Change in Cash$1.62M-$128K-$1.65M-$7.3M-$11.49M$11.97M
Supplementary Data
Operating Cash Flow-$5.29M-$7.87M-$10.97M-$11.77M-$15.73M-$20.61M
Capital Expenditure-$1K-$3-$70K-$30K-$5K-$49K
Free Cash Flow-$5.29M-$7.87M-$11.04M-$11.8M-$15.74M-$20.66M
Cash at Beginning$93K$220K$1.87M$9.17M$20.66M$8.7M
Cash at End$1.71M$93K$220K$1.87M$9.17M$20.66M